IDEXX Laboratories, Inc. (IDXX)
698.55
+26.51
(+3.94%)
USD |
NASDAQ |
Nov 04, 16:00
704.75
+6.20
(+0.89%)
After-Hours: 07:54
IDEXX Laboratories Enterprise Value : 55.81B for Nov. 4, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2026 | 55.81B |
| November 03, 2026 | 53.73B |
| November 02, 2026 | 53.69B |
| October 30, 2026 | 44.21B |
| October 29, 2026 | 46.16B |
| October 28, 2026 | 45.13B |
| October 27, 2026 | 45.00B |
| October 26, 2026 | 45.70B |
| October 23, 2026 | 44.93B |
| October 22, 2026 | 45.43B |
| October 21, 2026 | 44.38B |
| October 20, 2026 | 44.73B |
| October 19, 2026 | 44.57B |
| October 16, 2026 | 44.93B |
| October 15, 2026 | 43.89B |
| October 14, 2026 | 42.46B |
| October 13, 2026 | 41.77B |
| October 12, 2026 | 42.06B |
| October 09, 2026 | 41.59B |
| October 08, 2026 | 41.21B |
| October 07, 2026 | 40.70B |
| October 06, 2026 | 41.38B |
| October 05, 2026 | 42.30B |
| October 02, 2026 | 41.62B |
| October 01, 2026 | 41.57B |
| Date | Value |
|---|---|
| September 30, 2026 | 41.92B |
| September 29, 2026 | 42.97B |
| September 28, 2026 | 42.63B |
| September 25, 2026 | 41.86B |
| September 24, 2026 | 41.39B |
| September 23, 2026 | 42.07B |
| September 22, 2026 | 42.03B |
| September 21, 2026 | 41.54B |
| September 18, 2026 | 41.26B |
| September 17, 2026 | 40.85B |
| September 16, 2026 | 41.41B |
| September 15, 2026 | 41.18B |
| September 14, 2026 | 41.09B |
| September 11, 2026 | 40.71B |
| September 10, 2026 | 40.85B |
| September 09, 2026 | 41.53B |
| September 08, 2026 | 41.93B |
| September 04, 2026 | 43.13B |
| September 03, 2026 | 42.65B |
| September 02, 2026 | 43.41B |
| September 01, 2026 | 43.90B |
| August 31, 2026 | 44.81B |
| August 28, 2026 | 44.67B |
| August 27, 2026 | 43.89B |
| August 26, 2026 | 44.55B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Becton, Dickinson & Co. | 72.92B |
| DexCom, Inc. | 32.58B |
| Abbott Laboratories | 227.53B |
| Intuitive Surgical, Inc. | 163.16B |
| Teleflex, Inc. | 8.908B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 317.14M |
| Revenue (Quarterly) | 1.214B |
| Total Expenses (Quarterly) | 897.09M |
| EPS Diluted (Quarterly) | 4.012 |
| Gross Profit Margin (Quarterly) | 63.01% |
| Profit Margin (Quarterly) | 26.12% |
| Earnings Yield | 2.12% |
| Operating Earnings Yield | 2.71% |
| Normalized Earnings Yield | 2.112 |